These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 24041696

  • 1. GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody.
    Ogawa M, Nakamura N, Nakayama Y, Kurosaka A, Manya H, Kanagawa M, Endo T, Furukawa K, Okajima T.
    Biochem Biophys Res Commun; 2013 Oct 11; 440(1):88-93. PubMed ID: 24041696
    [Abstract] [Full Text] [Related]

  • 2. N-acetylglucosamine modification in the lumen of the endoplasmic reticulum.
    Ogawa M, Sawaguchi S, Furukawa K, Okajima T.
    Biochim Biophys Acta; 2015 Jun 11; 1850(6):1319-24. PubMed ID: 25791024
    [Abstract] [Full Text] [Related]

  • 3. Impaired O-linked N-acetylglucosaminylation in the endoplasmic reticulum by mutated epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase found in Adams-Oliver syndrome.
    Ogawa M, Sawaguchi S, Kawai T, Nadano D, Matsuda T, Yagi H, Kato K, Furukawa K, Okajima T.
    J Biol Chem; 2015 Jan 23; 290(4):2137-49. PubMed ID: 25488668
    [Abstract] [Full Text] [Related]

  • 4. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
    Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, Muntoni F, Lee H, Nelson SF, Yu L, Campbell KP.
    Science; 2013 Aug 23; 341(6148):896-9. PubMed ID: 23929950
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
    Voglmeir J, Kaloo S, Laurent N, Meloni MM, Bohlmann L, Wilson IB, Flitsch SL.
    Biochem J; 2011 Jun 01; 436(2):447-55. PubMed ID: 21361872
    [Abstract] [Full Text] [Related]

  • 9. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E, Carss KJ, Cirak S, Foley AR, Torelli S, Willer T, Tambunan DE, Yau S, Brodd L, Sewry CA, Feng L, Haliloglu G, Orhan D, Dobyns WB, Enns GM, Manning M, Krause A, Salih MA, Walsh CA, Hurles M, Campbell KP, Manzini MC, UK10K Consortium, Stemple D, Lin YY, Muntoni F.
    Am J Hum Genet; 2013 Mar 07; 92(3):354-65. PubMed ID: 23453667
    [Abstract] [Full Text] [Related]

  • 10. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
    Hu Y, Li ZF, Wu X, Lu Q.
    PLoS One; 2011 Feb 09; 6(2):e16866. PubMed ID: 21347376
    [Abstract] [Full Text] [Related]

  • 11. A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein.
    Signorino G, Covaceuszach S, Bozzi M, Hübner W, Mönkemöller V, Konarev PV, Cassetta A, Brancaccio A, Sciandra F.
    Hum Mutat; 2018 Feb 09; 39(2):266-280. PubMed ID: 29134705
    [Abstract] [Full Text] [Related]

  • 12. Antibodies that detect O-linked β-D-N-acetylglucosamine on the extracellular domain of cell surface glycoproteins.
    Tashima Y, Stanley P.
    J Biol Chem; 2014 Apr 18; 289(16):11132-11142. PubMed ID: 24573683
    [Abstract] [Full Text] [Related]

  • 13. Crystal structures of β-1,4-N-acetylglucosaminyltransferase 2: structural basis for inherited muscular dystrophies.
    Yang JY, Halmo SM, Praissman J, Chapla D, Singh D, Wells L, Moremen KW, Lanzilotta WN.
    Acta Crystallogr D Struct Biol; 2021 Apr 01; 77(Pt 4):486-495. PubMed ID: 33825709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H, Endo T.
    Biochim Biophys Acta Gen Subj; 2017 Oct 01; 1861(10):2462-2472. PubMed ID: 28711406
    [Abstract] [Full Text] [Related]

  • 16. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T.
    PLoS One; 2011 Apr 19; 6(4):e18959. PubMed ID: 21526146
    [Abstract] [Full Text] [Related]

  • 17. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.
    Hu H, Li J, Zhang Z, Yu M.
    Neurosci Lett; 2011 Feb 01; 489(1):10-5. PubMed ID: 21129441
    [Abstract] [Full Text] [Related]

  • 18. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.
    Buysse K, Riemersma M, Powell G, van Reeuwijk J, Chitayat D, Roscioli T, Kamsteeg EJ, van den Elzen C, van Beusekom E, Blaser S, Babul-Hirji R, Halliday W, Wright GJ, Stemple DL, Lin YY, Lefeber DJ, van Bokhoven H.
    Hum Mol Genet; 2013 May 01; 22(9):1746-54. PubMed ID: 23359570
    [Abstract] [Full Text] [Related]

  • 19. [Recent Advances in α-dystroglycanopathy].
    Kuga A, Kanagawa M, Toda T.
    Brain Nerve; 2011 Nov 01; 63(11):1189-95. PubMed ID: 22068471
    [Abstract] [Full Text] [Related]

  • 20. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review.
    Taniguchi-Ikeda M, Morioka I, Iijima K, Toda T.
    Mol Aspects Med; 2016 Oct 01; 51():115-24. PubMed ID: 27421908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.